Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer
| Status: | Archived |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | February 2009 |
| End Date: | May 2011 |
A Randomized, Double-Blind, Multi-Center Phase II Trial of Exemestane (Aromasin®) Plus Dasatinib Versus Exemestane Plus Placebo in Advanced ER+ Breast Cancer After Disease Progression on a Non-Steroidal Aromatase Inhibitor
The purpose of this study is to determine whether exemestane plus dasatinib will be
well-tolerated and will increase progression-free survival in the treatment of advanced ER+
breast cancer
We found this trial at
3
sites
Click here to add this to my saved trials
Fox Chase Cancer Center Fox Chase has earned the prestigious designation from the National Cancer...
Click here to add this to my saved trials
Click here to add this to my saved trials